The Latest Analyst Ratings for Elevance Health
Portfolio Pulse from Benzinga Insights
Elevance Health (NYSE:ELV) has received 7 bullish and somewhat bullish ratings from analysts in the last quarter. The company's average 12-month price target is $555.43, a decrease of 1.72% from the previous average of $565.17.

July 07, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elevance Health has received positive analyst ratings, which could boost investor confidence. However, the decrease in the average price target may indicate a potential slowdown in growth.
Analyst ratings are a significant factor that investors consider when making investment decisions. The positive ratings for Elevance Health indicate a bullish sentiment among analysts, which could boost investor confidence and potentially drive the stock price up. However, the decrease in the average price target may suggest that analysts expect the company's growth to slow down, which could temper the stock's performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100